Mr Vargas joined Depomed as vice president of business development in December 2002, while Ms Cameron joined Depomed as controller in July 2007 and was named interim principal financial and accounting officer of the company in October 2007.
Prior to Depomed, Mr Vargas held the positions of vice president of finance at Worldres.com, director of finance at Kosan Biosciences, and director of business development of finance, and information technology at Anergen. Mr Vargas has received a BA degree in business economics from the University of California, Santa Barbara.
Before joining Depomed, Ms Cameron has served as the controller at Adeza Biomedical, director of finance and administration at Timi3 Systems, director of treasury and external reporting at KeraVision, and was a member of Ernst & Young’s audit practice. Ms Cameron holds a BA degree from California State University, East Bay.
Carl Pelzel, president and CEO of Depomed, said: “On behalf of the rest of the company and the board of directors, I’d like to congratulate Thadd and Tammy on their promotions. While Thadd demonstrated strong leadership and Depomed’s ability to close business development deals in this challenging environment, Tammy has done an outstanding job managing our financial function and strong cash position, which is of utmost importance in tight capital markets.”